Showing results (2431-2440 of 6,717) with videos related to

Sort By:
Pageof 672
Oncotargets and Therapy|April 27, 2018
Combination of SIRT1 and Src overexpression suggests poor prognosis in luminal breast cancerJie Tan, Yuyin Liu, Yusufu Maimaiti, et al.
Oncotargets and Therapy|April 27, 2018
Role of the NFκB-signaling pathway in cancerLongzheng Xia, Shiming Tan, Yujuan Zhou, et al.
Oncotargets and Therapy|April 27, 2018
Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinomaChangkun Huang, Zhichao Huang, Xiaokun Zhao, et al.
Oncotargets and Therapy|April 27, 2018
Efficacy of pemetrexed-based regimens in advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations after tyrosine kinase inhibitor failure: a systematic reviewBaoHui Han, LuLu Yang, Xin Wang, et al.
Oncotargets and Therapy|April 27, 2018
Profile of apalutamide in the treatment of metastatic castration-resistant prostate cancer: evidence to dateJulio T Chong, William K Oh, Bobby C Liaw
Oncotargets and Therapy|May 22, 2018
Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective studyYun Bai, Xian-Shu Gao, Shang-Bin Qin, et al.
Oncotargets and Therapy|May 22, 2018
WWC3 inhibits epithelial-mesenchymal transition of lung cancer by activating Hippo-YAP signalingQiang Han, Joachim Kremerskothen, Xuyong Lin, et al.
Oncotargets and Therapy|May 22, 2018
A 5-serum miRNA panel for the early detection of colorectal cancerShaohua Guo, Jiajin Zhang, Baishi Wang, et al.
Oncotargets and Therapy|May 22, 2018
Predicting initial margin status in breast cancer patients during breast-conserving surgeryZihao Pan, Liling Zhu, Qian Li, et al.
Oncotargets and Therapy|May 22, 2018
Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysisTingting Zhang, Fubin Feng, Wenge Zhao, et al.
Pageof 672